Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 27, 2019 - Issue 6
Submit an article Journal homepage
269
Views
11
CrossRef citations to date
0
Altmetric
Letter to the Editor

Management of Chronic Hypotony Following Bilateral Uveitis in a Patient Treated with Pembrolizumab for Cutaneous Metastatic Melanoma

Gerard ReidDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, Northern Ireland;Department of Ophthalmology, Warrington & Holton Hospitals NHS Foundation Trust, Lovely Lane, Warrington, UKCorrespondence[email protected]
,
Paul LoriganDepartment of Medical Oncology, The Christie Clinic, Manchester, UK
,
Heinrich HeimannDepartment of Ocular Oncology, The Royal Liverpool University Hospital, Liverpool, UK
&
Marta HovanDepartment of Ophthalmology, Warrington & Holton Hospitals NHS Foundation Trust, Lovely Lane, Warrington, UK
Pages 1012-1015 | Received 08 May 2017, Accepted 27 Mar 2018, Published online: 19 Apr 2018

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Michel M. Sun$suffix/text()$suffix/text(), Ralph D. Levinson$suffix/text()$suffix/text(), Artur Filipowicz$suffix/text()$suffix/text(), Stephen Anesi$suffix/text()$suffix/text(), Henry J. Kaplan$suffix/text()$suffix/text(), Wei Wang$suffix/text()$suffix/text(), Debra A. Goldstein$suffix/text()$suffix/text(), Sapna Gangaputra$suffix/text()$suffix/text(), Robert T. Swan$suffix/text()$suffix/text(), H. Nida Sen$suffix/text()$suffix/text() & Lynn K. Gordon$suffix/text()$suffix/text(). (2020) Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition. Ocular Immunology and Inflammation 28:2, pages 217-227.
Read now

Articles from other publishers (10)

A. Martens, P. P. Schauwvlieghe, A. Madoe, I. Casteels & S. Aspeslagh. (2023) Ocular adverse events associated with immune checkpoint inhibitors, a scoping review. Journal of Ophthalmic Inflammation and Infection 13:1.
Crossref
Dongchen Li, Li Yang, Feng Bai, Shun Zeng & Xiaoli Liu. (2022) Clinical Manifestations, Diagnosis, Treatment and Prognosis of Uveitis Induced by Anticancer Drugs: A Review of Literature. Brain Sciences 12:9, pages 1168.
Crossref
Florence Chaudot, Pascal Sève, Antoine Rousseau, Alexandre Thibault Jacques Maria, Pierre Fournie, Pierre Lozach, Jeremy Keraen, Marion Servant, Romain Muller, Baptiste Gramont, Sara Touhami, Habeeb Mahmoud, Pierre-Antoine Quintart, Stéphane Dalle, Olivier Lambotte, Laurent Kodjikian & Yvan Jamilloux. (2022) Ocular Inflammation Induced by Immune Checkpoint Inhibitors. Journal of Clinical Medicine 11:17, pages 4993.
Crossref
Nika Vrabic, Ana Fakin, Polona Jaki Mekjavic, Urska Janzic, Martina Vrankar & Natasa Vidovic Valentincic. (2022) Various clinical presentations of uveitis associated with durvalumab treatment. Radiology and Oncology 56:2, pages 129-137.
Crossref
Christine Fardeau, Mehdi Bencheqroun, Arielle Levy, Sophie Bonnin, Marie-Adélaïde Ferchaud, Leila Fardeau, Florence Coscas, Bahram Bodaghi & Bénédicte Lebrun-Vignes. (2021) Uveitis associated with cancer immunotherapy: long-term outcomes. Immunotherapy 13:18, pages 1465-1481.
Crossref
Julia Canestraro, Anna Do, Seth D. Potash, Joseph Panarelli, Meghan Berkenstock, David H. Abramson & Jasmine H. Francis. (2021) Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis). American Journal of Ophthalmology Case Reports 23, pages 101125.
Crossref
Yong Joon Kim, Jihei Sara Lee, Junwon Lee, Sung Chul Lee, Tae-im Kim, Suk Ho Byeon & Christopher Seungkyu Lee. (2020) Factors associated with ocular adverse event after immune checkpoint inhibitor treatment. Cancer Immunology, Immunotherapy 69:12, pages 2441-2452.
Crossref
Vidushi Golash & Goncalo Almeida. (2020) Pembrolizumab-related Bilateral Ocular Hypotony, Uveitis, Cataracts, Exudative Retinal, and Choroidal Detachments: An Unusual Success Story. Journal of Immunotherapy 43:9, pages 283-285.
Crossref
Heba T. Rihani & Wendy M. Smith. (2020) Drug-Induced Uveitis: Part 1. Advances in Ophthalmology and Optometry 5, pages 265-306.
Crossref
. (2019) Pembrolizumab. Reactions Weekly 1772:1, pages 269-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.